Evidence map›Paper›PMID 24163127›Full record

ArticleHuman molecular genetics2014

Genome-wide association study identifies multiple loci associated with bladder cancer risk.

Jonine D Figueroa, Yuanqing Ye, Afshan Siddiq, Montserrat Garcia-Closas, Nilanjan Chatterjee, Ludmila Prokunina-Olsson, Victoria K Cortessis, Charles Kooperberg, Olivier Cussenot, Simone Benhamou and 82 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 16 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 16 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

92 authors.

Jonine D FigueroaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Yuanqing Ye
Afshan Siddiq
Montserrat Garcia-Closas
Nilanjan Chatterjee
Ludmila Prokunina-Olsson
Victoria K Cortessis
Charles Kooperberg
Olivier Cussenot
Simone Benhamou
Jennifer Prescott
Stefano Porru
Colin P Dinney
Núria Malats
Dalsu Baris
Mark Purdue
Eric J Jacobs
Demetrius Albanes
Zhaoming Wang
Xiang Deng
Charles C Chung
Wei Tang
H Bas Bueno-de-Mesquita
Dimitrios Trichopoulos
Börje Ljungberg
Françoise Clavel-Chapelon
Elisabete Weiderpass
Vittorio Krogh
Miren Dorronsoro
Ruth Travis
Anne Tjønneland
Paul Brenan
Jenny Chang-Claude
Elio Riboli
David Conti
Manuela Gago-Dominguez
Mariana C Stern
Malcolm C Pike
David Van Den Berg
Jian-Min Yuan
Chancellor Hohensee
Rebecca Rodabough
Geraldine Cancel-Tassin
Morgan Roupret
Eva Comperat
Constance Chen
Immaculata De Vivo
Edward Giovannucci
David J Hunter
Peter Kraft
Sara Lindstrom
Angela Carta
Sofia Pavanello
Cecilia Arici
Giuseppe Mastrangelo
Ashish M Kamat
Seth P Lerner
H Barton Grossman
Jie Lin
Jian Gu
Xia Pu
Amy Hutchinson
Laurie Burdette
William Wheeler
Manolis Kogevinas
Adonina Tardón
Consol Serra
Alfredo Carrato
Reina García-Closas
Josep Lloreta
Molly Schwenn
Margaret R Karagas
Alison Johnson
Alan Schned
Karla R Armenti
G M Hosain
Gerald Andriole
Robert Grubb
Amanda Black
W Ryan Diver
Susan M Gapstur
Stephanie J Weinstein
Jarmo Virtamo
Chris A Haiman
Maria T Landi
Neil Caporaso
Joseph F Fraumeni
Paolo Vineis
Xifeng Wu
Debra T Silverman
Stephen Chanock
Nathaniel Rothman

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLETT, WALTER C. · 1991 to 2009
$41.8M
Targeting Ral GTPases in Bladder CancerP50CA091846 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., MCCONKEY, DAVID J. · 2001 to 2018
$37.4M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
Premonopausal Hormone Levels and Risk of Breast CancerR01CA067262 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HANKINSON, SUSAN E · 2002 to 2011
$11.9M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
Silencing of Apoptotic Pathways in TCC by DNA MethylationP01CA086871 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JONES, PETER A · 2002 to 2006
$6.8M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
Cancer Research UK 16491CCR NIH HHS N01 RC037004NCI NIH HHS 1P01CA86871NCI NIH HHS 1R01CA114665NCI NIH HHS CA055075NCI NIH HHS CA34627NCI NIH HHS HHSN261201000006CNCI NIH HHS N01 CN045165NCI NIH HHS N02 CP001037NCI NIH HHS N02 CP011015NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA086871NCI NIH HHS P01 CA087969NCI NIH HHS P01 CA87969NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA091846NCI NIH HHS P50 CA 91846NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA065726NCI NIH HHS R01 CA067262NCI NIH HHS R01 CA074880NCI NIH HHS R01-CA089715NCI NIH HHS R01 CA114665NCI NIH HHS R01CA114665NCI NIH HHS R01 CA49449NCI NIH HHS R01CA65726NCI NIH HHS R01 CA67262NCI NIH HHS R01 CA 74880NCI NIH HHS U01 CA 127615NCI NIH HHS U01 CA127615NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA176726NCI NIH HHS UM1CA176726NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01HG004438NHGRI NIH HHS U01 HG004446NHGRI NIH HHS U01HG004446NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNHLBI NIH HHS R01HL091172-01NIA NIH HHS HHSN271201100004CWHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

Candidate gene and genome-wide association studies (GWAS) have identified 11 independent susceptibility loci associated with bladder cancer risk. To discover additional risk variants, we conducted a new GWAS of 2422 bladder cancer cases and 5751 controls, followed by a meta-analysis with two independently published bladder cancer GWAS, resulting in a combined analysis of 6911 cases and 11 814 controls of European descent. TaqMan genotyping of 13 promising single nucleotide polymorphisms with P < 1 × 10(-5) was pursued in a follow-up set of 801 cases and 1307 controls. Two new loci achieved genome-wide statistical significance: rs10936599 on 3q26.2 (P = 4.53 × 10(-9)) and rs907611 on 11p15.5 (P = 4.11 × 10(-8)). Two notable loci were also identified that approached genome-wide statistical significance: rs6104690 on 20p12.2 (P = 7.13 × 10(-7)) and rs4510656 on 6p22.3 (P = 6.98 × 10(-7)); these require further studies for confirmation. In conclusion, our study has identified new susceptibility alleles for bladder cancer risk that require fine-mapping and laboratory investigation, which could further understanding into the biological underpinnings of bladder carcinogenesis.

Indexed as

Genetic LociGenome-Wide Association StudyCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumMeta-Analysis as TopicPolymorphism, Single NucleotideRiskUrinary Bladder Neoplasms

Identifiers

PMID24163127
PMCPMC3919005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.